1126422-56-7Relevant academic research and scientific papers
A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitors
Chen, Kevin X.,Lesburg, Charles A.,Vibulbhan, Bancha,Yang, Weiying,Chan, Tin-Yau,Venkatraman, Srikanth,Velazquez, Francisco,Zeng, Qingbei,Bennett, Frank,Anilkumar, Gopinadhan N.,Duca, Jose,Jiang, Yueheng,Pinto, Patrick,Wang, Li,Huang, Yuhua,Selyutin, Oleg,Gavalas, Stephen,Pu, Haiyan,Agrawal, Sony,Feld, Boris,Huang, Hsueh-Cheng,Li, Cheng,Cheng, Kuo-Chi,Shih, Neng-Yang,Kozlowski, Joseph A.,Rosenblum, Stuart B.,Njoroge, F. George
, p. 2089 - 2101 (2012)
Starting from indole-based C-3 pyridone HCV NS5B polymerase inhibitor 2, structure-activity relationship (SAR) investigations of the indole N-1 benzyl moiety were performed. This study led to the discovery of irreversible inhibitors with p-fluoro-sulfone- or p-fluoro-nitro-substituted N-1 benzyl groups which achieved breakthrough replicon assay potency (EC50 = 1 nM). The formation of a covalent bond with adjacent cysteine-366 thiol was was proved by mass spectroscopy and X-ray crystal structure studies. The C-5 ethyl C-2 carboxylic acid derivative 47 had an excellent oral area-under-the-curve (AUC) of 18 μM?h (10 mg/kg). Its oral exposure in monkeys and dogs was also very good. The NMR ALARM assay, mass spectroscopy experiments, in vitro counter screening, and toxicology assays demonstrated that the covalent bond formation between compound 47 and the protein was highly selective and specific. The overall excellent profile of 47 made it an interesting candidate for further investigation.
TETRACYCLIC INDOLE DERIVATIVES AND METHODS OF USE THEREOF
-
Page/Page column 104, (2009/04/25)
The present invention relates to Tetracyclic Indole Derivatives, compositions comprising at least one Tetracyclic Indole Derivative, and methods of using the Tetracyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
